Stockscreener 앱 받기
125.17
0.61%
0.76
시간 외 거래:
125.17
전일 마감가:
$124.41
열려 있는:
$124.29
하루 거래량:
506.62K
Relative Volume:
0.80
시가총액:
$6.25B
수익:
$338.46M
순이익/손실:
$-310.96M
주가수익비율:
-19.17
EPS:
-6.53
순현금흐름:
$-132.82M
1주 성능:
+3.21%
1개월 성능:
+20.83%
6개월 성능:
+0.06%
1년 성능:
+33.60%
1일 변동 폭
$122.56
$125.25
1주일 범위
$120.72
$125.25
52주 변동 폭
$75.56
$139.13
Axsome Therapeutics Inc Stock (AXSM) Company Profile
명칭
Axsome Therapeutics Inc
전화
(212) 332-3241
주소
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
AXSM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AXSM
Axsome Therapeutics Inc
|
125.17 | 6.21B | 338.46M | -310.96M | -132.82M | -6.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 재개 | Wells Fargo | Overweight |
| 2025-07-03 | 재개 | Morgan Stanley | Overweight |
| 2025-06-03 | 개시 | Oppenheimer | Outperform |
| 2025-04-07 | 개시 | Jefferies | Buy |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-12-31 | 재확인 | Mizuho | Outperform |
| 2024-09-03 | 개시 | Wells Fargo | Overweight |
| 2024-08-06 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-07-22 | 개시 | Needham | Buy |
| 2024-04-29 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-03-19 | 개시 | Robert W. Baird | Outperform |
| 2024-02-06 | 개시 | UBS | Buy |
| 2024-01-25 | 개시 | RBC Capital Mkts | Outperform |
| 2023-12-13 | 개시 | Citigroup | Buy |
| 2023-08-08 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-01-05 | 개시 | Piper Sandler | Neutral |
| 2022-11-01 | 개시 | Loop Capital | Buy |
| 2022-09-07 | 재개 | Mizuho | Buy |
| 2021-08-10 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-10 | 개시 | Berenberg | Buy |
| 2021-01-08 | 개시 | Jefferies | Buy |
| 2020-12-16 | 개시 | Mizuho | Buy |
| 2020-09-29 | 개시 | BofA Securities | Underperform |
| 2020-09-10 | 개시 | Morgan Stanley | Overweight |
| 2020-04-28 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-14 | 개시 | Cowen | Outperform |
| 2019-12-30 | 재확인 | H.C. Wainwright | Buy |
| 2019-12-17 | 재확인 | H.C. Wainwright | Buy |
| 2019-12-16 | 재확인 | Guggenheim | Buy |
| 2019-10-16 | 개시 | Guggenheim | Buy |
| 2019-09-18 | 개시 | William Blair | Outperform |
| 2019-05-28 | 개시 | SunTrust | Buy |
| 2019-05-23 | 재확인 | H.C. Wainwright | Buy |
| 2019-04-08 | 개시 | SVB Leerink | Outperform |
| 2019-03-15 | 재확인 | H.C. Wainwright | Buy |
| 2016-10-03 | 재개 | Brean Capital | Buy |
| 2015-12-15 | 개시 | Cantor Fitzgerald | Buy |
| 2015-12-14 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Axsome Therapeutics Inc 주식(AXSM)의 최신 뉴스
What does recent volatility data suggest for Axsome Therapeutics Inc2025 Breakouts & Breakdowns & Free Expert Verified Stock Movement Alerts - Newser
Cormorant Asset Management LP Trims Stock Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
What does recent volatility data suggest for Axsome Therapeutics Inc.July 2025 Analyst Calls & Weekly Stock Breakout Alerts - Newser
Russell Investments Group Ltd. Sells 16,799 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. $AXSM Holdings Decreased by Point72 Europe London LLP - MarketBeat
PDT Partners LLC Has $5.97 Million Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Ieq Capital LLC Purchases New Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome therapeutics director Saad sells $1.14 million in shares By Investing.com - Investing.com Canada
Axsome therapeutics director Saad sells $1.14 million in shares - Investing.com
Ranking Axsome Therapeutics Inc. among high performing stocks via toolsQuarterly Profit Review & High Accuracy Buy Signal Tips - Newser
Applying big data sentiment scoring on Axsome Therapeutics Inc.July 2025 PreEarnings & Weekly High Momentum Picks - Newser
Landscape Capital Management L.L.C. Makes New $632,000 Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Published on: 2025-09-05 14:08:02 - Newser
Is Axsome Therapeutics Inc. a stock for growth or value investorsWeekly Profit Recap & High Conviction Buy Zone Picks - خودرو بانک
Best data tools to analyze Axsome Therapeutics Inc. stockTrade Signal Summary & Technical Pattern Alert System - Newser
Using AI based signals to follow Axsome Therapeutics Inc.July 2025 Pullbacks & Weekly High Return Opportunities - Newser
BVF Inc. IL Increases Stock Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Why Axsome Therapeutics Inc. is moving today2025 Historical Comparison & Smart Investment Allocation Tips - Newser
Custom watchlist performance reports with Axsome Therapeutics Inc.Weekly Investment Report & Fast Entry Momentum Alerts - Newser
Multi asset correlation models including Axsome Therapeutics Inc.Earnings Trend Report & High Conviction Investment Ideas - Newser
Axsome Therapeutics (NASDAQ:AXSM) Director Sells $1,665,227.52 in Stock - MarketBeat
Axsome Therapeutics at Cantor Conference: Strategic Growth in Brain Health By Investing.com - Investing.com Canada
Driehaus Capital Management LLC Makes New Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Is Axsome Therapeutics Inc.’s growth already priced inCPI Data & Safe Swing Trade Setup Alerts - khodrobank.com
Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years - The Globe and Mail
Will Axsome Therapeutics Inc. bounce back from current supportWeekly Gains Summary & High Return Trade Opportunity Guides - Newser
Forecasting Axsome Therapeutics Inc. price range with options dataJuly 2025 Review & Weekly High Potential Alerts - Newser
Wells Fargo Initiates Coverage on Axsome Therapeutics with Overweight Rating and $163 Price Target - AInvest
Relative strength of Axsome Therapeutics Inc. in sector analysisQuarterly Portfolio Review & Long-Term Safe Investment Plans - Newser
Sector ETF performance correlation with Axsome Therapeutics Inc.Volume Spike & Proven Capital Preservation Methods - Newser
Using Bollinger Bands to evaluate Axsome Therapeutics Inc.Portfolio Growth Summary & Momentum Based Trading Signals - Newser
Applying chart zones and confluence areas to Axsome Therapeutics Inc.July 2025 EndofMonth & Safe Capital Growth Tips - Newser
Is now a turning point for Axsome Therapeutics Inc.Dip Buying & Verified Swing Trading Watchlist - Newser
Axsome at Wells Fargo Conference: Growth and Strategic Expansions - Investing.com
Axsome initiated with Overweight at Wells Fargo on Alzheimer's drug potential - MSN
Wells Fargo Initiates Axsome Therapeutics with Overweight Rating, $163 Price Target - AInvest
Axsome Therapeutics Insider Sold Shares Worth $7,303,400, According to a Recent SEC Filing - 富途牛牛
Why Is Axsome (AXSM) Up 19.2% Since Last Earnings Report? - Yahoo Finance
Will Axsome Therapeutics Inc. stock recover after recent dropEarnings Trend Report & Technical Buy Zone Confirmation - Newser
What to do if you’re stuck in Axsome Therapeutics Inc.Watch List & Safe Capital Investment Plans - Newser
What’s the recovery path for long term holders of Axsome Therapeutics Inc.2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - Newser
Axsome Therapeutics stock rated Overweight by Wells Fargo - Investing.com Australia
Published on: 2025-09-03 05:51:54 - Newser
Tema Etfs LLC Takes Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Chart based analysis of Axsome Therapeutics Inc. trendsCPI Data & Weekly Top Performers Watchlists - Newser
What’s next for Axsome Therapeutics Inc. stock price2025 Market WrapUp & Expert-Curated Trade Recommendations - Newser
What earnings revisions data tells us about Axsome Therapeutics Inc.Trade Signal Summary & Daily Oversold Stock Bounce Ideas - Newser
Published on: 2025-09-03 02:19:56 - Newser
Northern Trust Corp Buys 8,469 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics Inc (AXSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Axsome Therapeutics Inc 주식 (AXSM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Saad Mark E | Director |
Sep 05 '25 |
Sale |
125.07 |
9,127 |
1,141,514 |
10,002 |
1.40%
자본화:
|
볼륨(24시간):